E. M. Grasbon-Frodl - Concepedia

Author

E. M. Grasbon-Frodl

Also Known As

E M Grasbon-Frodl, E. Grasbon-Frodl, E. M. Grasbon-Frodl, E.M Grasbon-Frodl, E.M. Grasbon-Frodl, Eva Grasbon-Frodl, Eva Grasbon‐Frodl, Eva M. Grasbon-Frodl, Eva M. Grasbon‐Frodl, Eva Maria Grasbon-Frodl

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Max Planck Institute of Neurobiology Lund University Wakayama Medical University Max Planck Society

About

E. M. Grasbon-Frodl is an author at Ludwig-Maximilians-Universität München specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1K
2	Social Sciences	6	6	238
3	Cell Biology	3	3	108
4	Natural Sciences	2	2	98
5	Allergy	1	1	10

E. M. Grasbon-Frodl

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance Uta Heinemann, Anna Krasnianski, Daniela Varges, Brain	2007	196
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas E. M. Grasbon-Frodl, Friedrich W. Kreth, Michael Ruiter, International Journal of Cancer	2007	152
Antioxidant treatment protects striatal neurons against excitotoxic insults Naoyuki Nakao, E. M. Grasbon-Frodl, Håkan Widner, Neuroscience Lipid PeroxidationNeuropharmacologyAntioxidant TreatmentNeuroprotectionNeurology	1996	91
Microglia and the Development of Spongiform Change in Creutzfeldt-Jakob Disease Ulrich V. Eitzen, Rupert Egensperger, Siegfried Kösel, Journal of Neuropathology & Experimental Neurology Creutzfeldt-jakob DiseaseNeuroanatomyMedicineClass Ii-positive MicrogliaImmunology	1998	90
Loss of glycosylation associated with the T183A mutation in human prion disease E. M. Grasbon-Frodl, Holger Lorenz, Ulrike Mann, Acta Neuropathologica GlycoproteomicsCreutzfeldt-jakob DiseaseGenetic DisorderMedicineGenetics	2004	87
Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease Siegfried Kösel, E. M. Grasbon-Frodl, Ulrike Mautsch, Neurogenetics Mitochondrial FunctionMedicineParkinson DiseaseGeneticsNovel Mutations	1998	85
Analysis of Mitochondrial Targeting Sequence and Coding Region Polymorphisms of the Manganese Superoxide Dismutase Gene in German Parkinson Disease Patients E. M. Grasbon-Frodl, Siegfried Kösel, Ulrich Müller, Biochemical and Biophysical Research Communications Mitochondrial FunctionGeneticsMolecular BiologyMitochondrial Targeting SequenceNeurochemical Biomarkers	1999	81
Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. Manuel B. Graeber, Siegfried Kösel, E. M. Grasbon-Frodl, Neurogenetics Neurodegenerative DiseasesAlzheimer's DiseaseApoe GenotypeAuguste DVascular Dementia	1998	79
DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease Naoyuki Nakao, E. M. Grasbon-Frodl, Håkan Widner, Neuroscience Lateral Ganglionic EminenceDarpp-32-rich ZonesNeuroregenerationSkilled PawNeuroanatomy	1996	77
Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP53 Mutations in World Health Organization Grade II Gliomas Niklas Thon, Sabina Eigenbrod, E. M. Grasbon-Frodl, Journal of Neuropathology & Experimental Neurology	2009	70

Page 1